CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade ALX Oncology Holdings Inc. - ALXO CFD

13.50
7.18%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.14
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 14.63
Open 14.94
1-Year Change 120.03%
Day's Range 13.58 - 14.96
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 23, 2024 14.63 0.05 0.34% 14.58 15.26 13.98
May 22, 2024 14.97 1.47 10.89% 13.50 15.00 13.50
May 21, 2024 13.58 -0.08 -0.59% 13.66 14.14 13.26
May 20, 2024 13.75 0.00 0.00% 13.75 14.08 13.66
May 17, 2024 14.16 -0.15 -1.05% 14.31 14.65 14.08
May 16, 2024 14.62 -0.19 -1.28% 14.81 14.92 14.36
May 15, 2024 14.98 -0.17 -1.12% 15.15 15.74 14.93
May 14, 2024 15.15 -0.82 -5.13% 15.97 16.16 14.79
May 13, 2024 15.57 -0.58 -3.59% 16.15 16.87 15.40
May 10, 2024 16.14 -0.86 -5.06% 17.00 17.37 15.84
May 9, 2024 16.65 0.56 3.48% 16.09 17.03 15.94
May 8, 2024 16.55 -0.68 -3.95% 17.23 17.53 16.00
May 7, 2024 17.52 1.85 11.81% 15.67 17.79 15.19
May 6, 2024 15.77 0.41 2.67% 15.36 16.40 15.36
May 3, 2024 15.36 -1.55 -9.17% 16.91 17.00 15.21
May 2, 2024 16.61 -0.54 -3.15% 17.15 17.24 16.50
May 1, 2024 16.90 0.15 0.90% 16.75 17.43 16.75
Apr 30, 2024 16.99 0.50 3.03% 16.49 17.11 16.38
Apr 29, 2024 16.92 0.12 0.71% 16.80 17.40 16.51
Apr 26, 2024 16.85 0.33 2.00% 16.52 17.28 16.25

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

ALX Oncology Holdings Inc. Company profile

About ALX Oncology Holdings Inc

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company. The Company is focused on enabling patients to fight cancer by developing therapies that block the cluster of differentiation 47 (CD47) checkpoint pathway and bridge the innate and adaptive immune system. The Company is developing a checkpoint inhibitor designed to have an affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches. Its lead product candidate, ALX148, is a CD47 blocking therapeutic. ALX148 is a fusion protein that combines a CD47 binding domain with its inactivated fragment crystallizable (Fc) domain. The CD47 binding domain of ALX148 is an affinity enhanced extracellular domain of signal regulatory protein alpha (SIRPa), a protein that is the natural receptor to CD47 found on myeloid cells. Its programs are focused on targeting CD47 across various oncology indications.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, ALX Oncology Holdings Inc revenues decreased from $1.2M to $0K. Net loss applicable to common stockholders increased 64% to $83.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Reserach and developement increase of 76% to $46.5M (expense).

Industry: Bio Therapeutic Drugs

323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

News

Copper price slumps as traders take profits, where to next?

Copper price drops over 5% on Thursday as traders take profits following the FOMC meeting minutes.

16:17, 24 May 2024

Market analysis: EUR/GBP driven by diverging policy expectations

The EURGBP is driven by the question: which cuts first, the ECB or the BOE? Currently, swaps markets (chart below) imply that it will be the ECB (blue line).

13:46, 24 May 2024

UK CPI Preview: Will inflation return to 2% as the BoE predicts? And how will it affect GBP?

The latest round of inflation data will be released at 22 April at 7 am BST and investors are likely going to be paying close attention.

15:44, 21 May 2024

Reserve Bank of New Zealand Preview: RBNZ could become more dovish as inflation eases and growth softens

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, May 22, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

15:29, 21 May 2024

Nvidia Q1 Earnings Preview: Analysts forecast another blockbuster set of results

Nvidia (NVDA) reports its Q1 results after the closing bell on Wednesday, May 22nd. We preview what to expect from Nvidia’s earnings and analyse its stock's technicals.

14:57, 21 May 2024
CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

Stock market crash: how far can the S&P 500 go?

After a remarkably strong first quarter, the US stock market pulled back in April for the first time since October last year.

11:46, 10 May 2024

People also watch

Oil - Crude

77.71 Price
+0.900% 1D Chg, %
Long position overnight fee 0.0073%
Short position overnight fee -0.0293%
Overnight fee time 21:00 (UTC)
Spread 0.040

XRP/USD

0.54 Price
+2.800% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,336.61 Price
+0.370% 1D Chg, %
Long position overnight fee -0.0199%
Short position overnight fee 0.0117%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

68,131.10 Price
+0.440% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading